FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

771073006: Lymphoproliferative disorder caused by methotrexate (disorder)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3704193017 Lymphoproliferative disorder caused by methotrexate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3704194011 Lymphoproliferative disorder caused by methotrexate (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3704195012 Methotrexate-associated lymphoproliferative disorder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5404986014 Methotrexate-associated lymphoproliferative disorders are rare immunodeficiency-associated lymphoproliferative diseases characterized by lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
5404987017 Methotrexate-associated lymphoproliferative disorders are rare immunodeficiency-associated lymphoproliferative diseases characterised by lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3704193017 Lymphoproliferative disorder caused by methotrexate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3704194011 Lymphoproliferative disorder caused by methotrexate (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3704195012 Methotrexate-associated lymphoproliferative disorder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3704196013 Rare immunodeficiency-associated lymphoproliferative disease with characteristics of lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
5404986014 Methotrexate-associated lymphoproliferative disorders are rare immunodeficiency-associated lymphoproliferative diseases characterized by lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
5404987017 Methotrexate-associated lymphoproliferative disorders are rare immunodeficiency-associated lymphoproliferative diseases characterised by lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3390031001000112 Lymphoproliferative Krankheit, Methotrexat-assozierte de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
6347371000241119 affection lymphoproliférative causée par le méthotrexate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
6347371000241119 affection lymphoproliférative causée par le méthotrexate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3390031001000112 Lymphoproliferative Krankheit, Methotrexat-assozierte de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lymphoproliferative disorder caused by methotrexate Is a Drug-induced immunodeficiency true Inferred relationship Existential restriction modifier (core metadata concept)
Lymphoproliferative disorder caused by methotrexate Causative agent (attribute) Methotrexate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Lymphoproliferative disorder caused by methotrexate Associated morphology Lymphoproliferative disorder true Inferred relationship Existential restriction modifier (core metadata concept) 1
Lymphoproliferative disorder caused by methotrexate Is a Lymphoproliferative disorder false Inferred relationship Existential restriction modifier (core metadata concept)
Lymphoproliferative disorder caused by methotrexate Finding site Structure of immune system (body structure) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Lymphoproliferative disorder caused by methotrexate Pathological process (attribute) Abnormal immune process (qualifier value) false Inferred relationship Existential restriction modifier (core metadata concept) 2
Lymphoproliferative disorder caused by methotrexate Is a Iatrogenic immunodeficiency-associated lymphoproliferative disorder (disorder) true Inferred relationship Existential restriction modifier (core metadata concept)
Lymphoproliferative disorder caused by methotrexate Finding site Structure of immune system (body structure) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Lymphoproliferative disorder caused by methotrexate Pathological process (attribute) Abnormal immune process (qualifier value) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Component annotation with string value reference set (foundation metadata concept)

Back to Start